# Efficacy and Safety of TwHF and MTX in Patients With Rheumatoid Arthritis

> **NCT03324412** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 216 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Treatment of MTX
- **DRUG:** Treatment of MTX and TwHF

## Key facts

- **NCT ID:** NCT03324412
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-28
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-09-30
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2017-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03324412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03324412, "Efficacy and Safety of TwHF and MTX in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03324412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*